Novak Alfred J 4
4 · Pasithea Therapeutics Corp. · Filed Oct 24, 2022
Insider Transaction Report
Form 4
Novak Alfred J
Director
Transactions
- Award
Stock Option (to acquire Common Stock)
2022-10-21+100,000→ 100,000 totalExercise: $1.06From: 2023-10-21Exp: 2032-10-21→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The Reporting Person was granted 100,000 stock options. The stock options have a ten-year term and vest over two years, subject to Mr. Novak's continued service as a director, one-half vesting on the first anniversary of the grant date, and the remaining 50% vesting on the second anniversary of the grant date.